Prion protein aggregation assays in the diagnosis of human prion diseases

Papers of special note have been highlighted as: • of interest; •• of considerable interest.

References

• 1 van Rheede T, Smolenaars MM, Madsen O, de Jong WW. Molecular evolution of the mammalian protein. Mol. Biol. Evol. 20(1), 111–121 (2003).
  Medline CASGoogle Scholar
• 2 Will RG, Alperovitch A, Poser S. Descriptive epidemiology of Creutzfeldt–Jakob disease in six European countries, 1993–1995. Ann. Neurol. 43, 763–767 (1998).
  Medline CASGoogle Scholar
• 3 Berman P, Davidson GS, Becker LE. Progressive neurological deterioration in a 14-year-old girl. Paediatr. Neurosci. 14, 42–49 (1988).
  Medline CASGoogle Scholar
• 4 Buganza M, Ferrar S, Cecchini ME et al. The oldest old Creutzfeldt–Jakob disease case. J. Neurol. Neurosurg. Psychiatr. 80, 1140–1142 (2009).
  Medline CASGoogle Scholar
• 5 Parchi P, Giese A, Capellari S et al. Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phentotypical analysis of 300 subjects. Ann. Neurol. 46(2), 224–233 (1999).
  Medline CASGoogle Scholar
• 6 Gibbs CJ Jr, Joy A, Heffner R. Clinical and pathological features and laboratory confirmation of Creutzfeldt–Jakob disease in a recipient of pituitary-derived human growth hormone. Lancet 313, 734–738 (1985).
  Google Scholar
• 7 Billette de Villemeur T, Deslys JP, Pradel A et al. Creutzfeldt–Jakob disease from contaminated growth hormone extracts in France. Neurology 47(3), 690–695 (1996).
  Medline CASGoogle Scholar
• 8 Dumble LJ, Klein RD. Creutzfeldt–Jakob legacy for Australian women treated with human pituitary gonadotrophins. Lancet 340, 847–848 (1992).
  Medline CASGoogle Scholar
• 9 Ironside JW, Knight RSG, Head MW. Iatrogenic Creutzfeldt–Jakob disease. In: Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Dickson D, Weller RO (Eds). Wiley-Blackwell (2011).
  Google Scholar
• 10 Glasse R. Cannibalism in the Kuru region of New Guinea. Trans. NY Acad. Sci. 29, 748–754 (1967).
  Medline CASGoogle Scholar
• 11 Will RG, Ironside JW, Zeidler M. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347, 921–925 (1996).•• First description of variant Creutzfeldt–Jakob disease in the UK.
  Medline CASGoogle Scholar
• 12 Chazot G, Broussolle E, Lapras CI et al. New variant of Creutzfeldt–Jakob disease in a 26-year-old French man. Lancet 349, 1181 (1996).
  Google Scholar
• 13 Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389, 498–501 (1997).•• This study produces evidence that vCJD and BSE are caused by the same agent.
  Medline CASGoogle Scholar
• 14 Collinge J, Sidle KC, Meads J, Ironside JW, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383, 685–690 (1997).•• This study produces evidence that vCJD and BSE are caused by the same agent but uses a different technique to Bruce et al., adding more weight to the overall evidence.
  Google Scholar
• 15 Zeidler M, Stewart GE, Barraclough CR et al. New variant Creutzfeldt–Jakob disease: neurological features and diagnostic tests. Lancet 350, 903–907 (1997).
  Medline CASGoogle Scholar
• 16 Zeidler M, Johnstone EC, Bamber RW et al. New variant Creutzfeldt–Jakob disease: psychiatric features. Lancet 350, 908–910 (1997).
  Medline CASGoogle Scholar
• 17 Cousens SN, Zeidler M, Esmonde TF et al. Sporadic Creutzfeldt–Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970–96. BMJ 315(7105), 389–395 (1997).
  Medline CASGoogle Scholar
• 18 Hill AF, Zeidler M, Ironside JW, Collinge J. Diagnosis of new variant Creutzfeldt–Jakob disease by tonsil biopsy. Lancet 349, 99–100 (1997).
  Medline CASGoogle Scholar
• 19 Green AJE, Thompson EJ, Stewart GE et al. The use of CSF 14–3–3 and other brain-specific proteins in the diagnosis of variant Creutzfeldt–Jakob disease. J. Neurol. Neurosurg. Psychiatr. 70, 744–748 (2001).
  Medline CASGoogle Scholar
• 20 Zerr I, Kallenberg K, Summers DM. Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain 132, 2659–2668 (2009).
  Medline CASGoogle Scholar
• 21 WHO. Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. WHO, Geneva, Switzerland (1998).
  Google Scholar
• 22 Peden A, McGuire L, Appleford N et al. Sensitive and specific detection of sporadic Creutzfeldt–Jakob disease brain prion protein using real-time quaking induced conversion. J. Gen. Virol. 93(2), 438–449 (2012).
  Medline CASGoogle Scholar
• 23 Llewelyn CA, Hewitt PE, Knight RS et al. Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 368, 417–421 (2014).
  Google Scholar
• 24 Brown P, Cervenakova L, McShane LM et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt–Jakob disease in humans. Transfusion 39(11–12), 1169–1178 (1999).
  Medline CASGoogle Scholar
• 25 Kocisko DA, Come JH, Priola SA et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471–474 (1994).
  Medline CASGoogle Scholar
• 26 Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411(6839), 810–813 (2001).
  Medline CASGoogle Scholar
• 27 Castilla J, Saa P, Soto C. Detection of prions in blood. Nat. Med. 11(9), 982–985 (2005).
  Medline CASGoogle Scholar
• 28 Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281(46), 35245–35252 (2006).
  Medline CASGoogle Scholar
• 29 Gonzalez-Montalban N, Makarava N, Ostapchenko VG et al. Highly efficient protein misfolding cyclic amplification. PLoS Pathog. 7 (2011).
  Google Scholar
• 30 Thorne L, Terry LA. In vitro amplification of PrP^Sc derived from the brain and blood of sheep infected with scrapie. J. Gen. Virol. 89(12), 3177–3184 (2008).
  Medline CASGoogle Scholar
• 31 Murayama Y, Yoshioka M, Iwamaru Y et al. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci. Lett. 413(3), 270–273 (2007).
  Medline CASGoogle Scholar
• 32 Jones M, Peden A, Prowse CV et al. In vitro amplification of variant Creutzfeldt–Jakob disease PrP^Sc. J. Pathol. 213(1), 21–26 (2007).
  Medline CASGoogle Scholar
• 33 Franz M, Eiden M, Balkema-Buschmann A et al. Detection of PrP^Sc in peripheral tissues of clinically affected cattle after oral challenge with bovine spongiform encephalopathy. J. Gen. Virol. 93(12), 2740–2748 (2012).
  Medline CASGoogle Scholar
• 34 Kurt TD, Seelig DM, Schneider JR et al. Alteration of the chronic wasting disease species barrier by in vitro prion amplification. J. Virol. 85(17), 8528–8537 (2014).
  Google Scholar
• 35 Soto C, Anderes L, Suardi S et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett. 579, 638–642 (2005).
  Medline CASGoogle Scholar
• 36 Murayama Y, Yoshida M, Okada H et al. Urinary excretion and blood level of prions in scrapie-infected hamsters. J. Gen. Virol. 88, 2890–2898 (2007).
  Medline CASGoogle Scholar
• 37 Gonzalez-Romero D, Barria MA, Leon P, Morales R, Soto C. Dectection of infectious prions in urine. FEBS Lett. 582, 3161–3166 (2008).
  Medline CASGoogle Scholar
• 38 Douet JY, Zafar S, Perret-Liaudet A et al. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt–Jakob disease. Emerg. Infect. Dis. 20, 114–117 (2014).
  Medline CASGoogle Scholar
• 39 Rubenstein R, Chang B, Gray P et al. Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease. J. Virol. 85, 9031–9038 (2011).
  Medline CASGoogle Scholar
• 40 Haley NJ, Mathiason CK, Zabel MD, Telling GC, Hoover EA. Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer. PLoS ONE 4, 1–8 (2009).
  Google Scholar
• 41 Nichols TA, Spraker TR, Gidlewski T et al. Detection of prion protein in the cerebrospinal fluid of elk (Cervus candaerisis nelsoni) with chronic wasting disease using protein misfolding cyclic amplification. J. Vet. Diagn. Invest. 24, 746–749 (2012).
  MedlineGoogle Scholar
• 42 Murayama Y, Yoshioka M, Masujin K et al. Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrP(^Sc) and enable ultrasensitive detection of boving PrP(^Sc). PLoS ONE 5, e13152 (2010).
  MedlineGoogle Scholar
• 43 Murayama Y, Masujin K, Imamura M et al. Ultrasensitive detection of PrP^Sc in the cerebrospinal fluid and blood of macaques infected with bovine spongiform encephalopathy prion. J. Gen. Virol. 95, 2576–2588 (2014).
  Medline CASGoogle Scholar
• 44 Rubenstein R, Chang B, Gray P et al. A novel method for preclinical detection of PrP^Sc in blood. J. Gen. Virol. 91, 1883–1892 (2010).
  Medline CASGoogle Scholar
• 45 Jones M, Peden A, Yull H et al. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt–Jakob disease. Transfusion 49(2), 376–384 (2009).
  Medline CASGoogle Scholar
• 46 Nemecek J, Nag N, Carlson CM et al. Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from Macaque and human brains infected with variant Creutzfeldt–Jakob disease agent. PLoS ONE 8, e78710 (2013).
  Medline CASGoogle Scholar
• 47 Lacroux C, Comoy E, Moudjou M et al. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathogens 10, e1004202 (2014).•• This describes the first detection of abnormal PrPSc in the blood of patients with sCJD.
  MedlineGoogle Scholar
• 48 Xiao X, Yuan J, Cali I et al. Comparative study of prions in iatrogenic and sporadic Creutzfeldt–Jakob disease. J. Clin. Cell Immunol. 5, 240 (2014).
  MedlineGoogle Scholar
• 49 Moda F, Gambetti P, Notari S et al. Prions in the urine of patients with variant Creutzfeldt–Jakob disease. N. Engl. J. Med. 371, 530–539 (2014).•• This is of great interest as this describes a clincial test that may be able to distinguish vCJD from sCJD.
  MedlineGoogle Scholar
• 50 Rubenstein R, Chang B. Re-assessment of PrP^Sc distrubution in sporadic and variant CJD. PLoS ONE 8, e66352 (2013).
  Medline CASGoogle Scholar
• 51 Herzog C, Riviere J, Lescoutra-Etchegaray N et al. PrPTSE distribution in a primate model of variant, sporadic and iatrogenic Creutzfeldt–Jakob disease. J Virol 79, 14339–14345 (2005).
  Medline CASGoogle Scholar
• 52 Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 356, 999–1000 (2000).
  Medline CASGoogle Scholar
• 53 Llewelyn CA, Hewitt PE, Knight RS et al. Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 363, 417–421 (2004).
  Medline CASGoogle Scholar
• 54 Peden A, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinal vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527–529 (2004).
  MedlineGoogle Scholar
• 55 Brown P, Gibbs CJ Jr, Rodgers-Johnson P et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35, 513–529 (1994).
  Medline CASGoogle Scholar
• 56 Brown P. Creutzfeldt–Jakob disease: reflections on the risk from blood product therapy. Haemophilia 13, 33–40 (2007).
  Medline CASGoogle Scholar
• 57 Puopolo M, Ladogana A, Vetrugno V, Pocchiari M. Transmission of sporadic Creutzfeldt–Jakob disease by blood transfusion: risk or possible biases. Transfusion 51, 1556–1566 (2011).
  MedlineGoogle Scholar
• 58 Orrú CD, Wilham JM, Vascellari S, Hughson AG, Caughey B. New generation QuIC assays for prion seeding activity. Prion 6, 147–152 (2012).
  Medline CASGoogle Scholar
• 59 Atarashi R, Moore RA, Sim VL et al. Ultrasensitive detection of scrapie prion protein using seeded conversion recombinant prion protein. Nat. Methods 4, 645–650 (2007).
  Medline CASGoogle Scholar
• 60 Atarashi R, Wilham JM, Christensen L et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 5, 211–212 (2008).
  Medline CASGoogle Scholar
• 61 Bessen RA, Shearin H, Martinka S et al. Prion shedding from olfactory neuornes into nasal secretions. PLoS Pathog. 6, e1000837 (2010).
  MedlineGoogle Scholar
• 62 Orrú CD, Wilham JM, Hughson AG et al. Human variant Creutzfeldt–Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng. Des. Sel. 22, 515–521 (2009).
  Medline CASGoogle Scholar
• 63 Wilham JM, Orrú CD, Bessen RA. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bio-assays. PLoS 6(12), 1–15 (2010).
  Google Scholar
• 64 Vascellari S, Orrú CD, Hughson AG et al. Prion seeding activities of mouse scrapie strains with divergent PrP^Sc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. PLoS ONE 7, e48969 (2012).
  Medline CASGoogle Scholar
• 65 Elder AM, Henderson DM, Nalls AV et al. In vitro detection of prionaemia in TSE-infected cervids and hamsters. PLoS ONE 8, e80203 (2013).
  Medline CASGoogle Scholar
• 66 Haley NJ, van de Motter A, Carver S et al. Prion-seeding acitivity in cerebrospinal fluid of deer with chronic wasting disease. PLoS ONE 8, e81488 (2013).
  MedlineGoogle Scholar
• 67 Henderson DM, Davenport KA, Haley NJ et al. Quantitative assessment of prion infectivity in tissues and body fluids by RT-QuIC. J. Gen. Virol. 10, vir.0.069906–0 (2014) (Epub ahead of print).
  Google Scholar
• 68 Atarashi R, Satoh K, Sano K et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17, 175–178 (2011).•• Description of use of RT-QuIC in sCJD cases.
  Medline CASGoogle Scholar
• 69 Jarrett JT, Lansbury PT Jr. Seeding ‘one-dimensional crystallization’ of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055–1058 (2014).
  Google Scholar
• 70 McGuire L, Peden A, Orru C et al. Prion seeding activity in cerebrospinal fluid from patients with sporadic Creutzfeldt–Jakob disease patients using real-time QuIC analysis: a potential new clinical diagnostic test with high sensitivity and specificity. Ann. Neurol. 72(2), 278–285 (2012).•• Description of large-scale retrospective study into the value of RT-QuIC in sCJD.
  MedlineGoogle Scholar
• 71 Cramm M, Schmitz M, Karch A et al. Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol. Neurobiol. 51(1), 396–405 (2014).
  MedlineGoogle Scholar
• 72 Sanchez-Juan P, Green AJE, Ladogana A et al. CSF tests in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology 67, 637–643 (2006).
  Medline CASGoogle Scholar
• 73 Orrú CD, Bongianni M, Tonoli G et al. A test for Creutzfeldt–Jakob disease using nasal brushings. N. Engl. J. Med. 371, 519–529 (2014).• Use of nasal brushing and RT-QuIC in sCJD.
  Medline CASGoogle Scholar
• 74 Tabaton M, Monaco S, Cordone MP et al. Prion deposition in olfactory biopsy of sporadic CJD. Ann. Neurol. 55, 294–296 (2004).
  MedlineGoogle Scholar
• 75 Orrú CD, Hughson AG, Race B, Raymond GJ, Caughey B. Time course of prion seeding activity in cerebrospinal fluid of scrapie-infected hamsters after intratongue and intracerebral inoculations. J. Clin. Microbiol. 50, 1464–1466 (2012).
  MedlineGoogle Scholar
• 76 Sano K, Satoh K, Atarashi R et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QuIC assay. PLoS ONE 8, 1–4 (2013).
  Google Scholar
• 77 Orrú CD, Wilham JW, Raymond LD et al. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2, e00078–11 (2011).
  MedlineGoogle Scholar
• 78 Korth C, Stierli B, Striet P et al. Prion (PrP^Sc)-specific epitope defined by a monoclonal antibody. Nature 390, 74–77 (1997).
  Medline CASGoogle Scholar
• 79 Biasini E, Tapella L, Mantovani S et al. Immunoprecipitation of pathological prion protein aggregates. PLoS ONE 4, 7816 (2009).
  Google Scholar
• 80 Castilla J, Sáá P, Morales R et al. Protein misfolding cyclinc amplification for diagnosis and prion propagation studies. Methods Enzymol. 412, 3–21 (2006).
  Medline CASGoogle Scholar
• 81 Wroe SJ, Pal S, Siddique D et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt–Jakob disease associated with blood transfusion: a case report. Lancet 368, 2061–2067 (2006).
  MedlineGoogle Scholar
• 82 Gill N, Spencer Y, Richard-Loendt A et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347, 5675 (2013).
  Google Scholar